Development of a method for preparing octreotide derivative for diagnosis of neuroendocrine tumors
Currently the development of technologies for labeling somatostatin with technetium-99m for diagnosing radionuclide neuroendocrine tumors is under way. Somatostatin analogues are binded with technetium99m only by the preliminary addition of a chelating agent. Therefore, it is important to develop a...
Saved in:
Main Authors: | M. S. Larkina, E. V. Podrezova, O. D. Bragina, E. A. Tagirova, V. I. Chernov, M. S. Yusubov, E. A. Nesterov, V. S. Skuridin, S. V. Krivoshchekov, E. A. Yanovskaya, R. V. Gurto, M. V. Belousov |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2019-10-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/2402 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
by: L. Yu. Morgunov
Published: (2015-06-01) -
The development of a highly specific radiochemical compound based on labeled 99mtc recombinant molecules for targeted imaging of cells with the overexpression of Her-2 / neu
by: Olga D. Bragina, et al.
Published: (2017-10-01) -
Pharmacoeconomic analysis of lanreotide and prolonged-release octreotide in first- and second-line therapy of acromegaly
by: I. S. Krysanov, et al.
Published: (2025-05-01) -
A Multidisciplinary Approach to Managing Carcinoid Syndrome in Pregnant Women: Ensuring Maternal and Fetal Safety Trough Interdisciplinary Collaboration
by: Andreea Elena CONSTANTIN, et al.
Published: (2025-06-01) -
Towards Dual-Tracer SPECT for Prostate Cancer Imaging Using [<sup>99m</sup>Tc]Tc-PSMA-I&S and [<sup>111</sup>In]In-RM2
by: Carolina Giammei, et al.
Published: (2025-07-01)